Skip to main content

Table 4 SBRT of liver oligometastases

From: Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review

  Liver metastases (N) Dose (Gy × fr) Median follow up (mos) Actuarial LC rate (%)
     at 12 mos at 24 mos
Herfarth et al. 2001 [40] 56 14-26 × 1 6 75  
Wulf et al. 2001 [41] 23 30 × 3 9 76 61
Wulf et al. 2006 [42]. 51 variable dose × (1–3) 15 92 66
Hoyer et al. 2006 [43] 97/141*lesions 45 × 3 4.3 years   79
Méndez-Romero et al. 2006 [44] 34 37.5 × 3 13 100 86
Kavanagh et al. 2006 [45]. 36 60 × 3 19 93 (at 18 mos)  
Milano et al. 2008 [46]. 120/293*lesions 50 × 5 41   67
Rusthoven et al. 2009 [47]. 63 36 - 60 × 3 16 95 92
Van der Pool et al. 2010 [48] 31 37.5 - 45 × 3 26 100 74
Rule et al. 2010 [49]. 37 30 × 3 20   56
   50 × 5    89
   60 × 5    100
  1. LC: local control.
  2. * Ratio of liver oligometastases to total number of oligometastases.